Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure of Protalix BioTherapeutics, Inc. from 2017 to Q1 2025
-
Taxonomy & unit
-
us-gaap: pure
-
Description
-
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
-
Summary
-
Protalix BioTherapeutics, Inc. quarterly/annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and change rate from 2017 to Q1 2025.
- Protalix BioTherapeutics, Inc. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending 31 Mar 2025 was 0.21 pure, unchanged year-over-year.
- Protalix BioTherapeutics, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2024 was 0.21 pure, unchanged from 2023.
- Protalix BioTherapeutics, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0.21 pure, unchanged from 2022.
- Protalix BioTherapeutics, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2022 was 0.21 pure, unchanged from 2021.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Quarterly Change (%)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Annual (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Annual Change (%)